StockData
Charming Medical Ltd logo

Charming Medical Ltd (MCTA) stock

MCTANasdaqServices-Misc Health & Allied Services, NEC
Financials through fiscal 2026, year ended Mar 31, 2026Last filing: 20-F on Jul 30, 2026Score 3/30
$29.35+0.00 (0.00%)

Close on Nov 5, 2026Market cap $504.17MP/E –Yield –

Charming Medical Ltd saw revenue fall 22.7% to $4.81M over fiscal 2026. Operating income fell 102.1% to -$29.24K, moving the operating margin from 22.3% to -0.6%. Free cash flow was -$1.56M, down 1224.2% from a year earlier. At the latest close the market valued the company at $504.17M.

Revenue
$4.81M
-22.7% vs. a year earlier
Operating income
-$29.24K
-102.1% vs. a year earlier
Free cash flow
-$1.56M
-1224.2% vs. a year earlier
EPS, diluted
$0.00
-100.0% vs. a year earlier

Key statistics

Valuation at the latest close; fundamentals over fiscal 2026, balances at Mar 31, 2026

Valuation

Market cap
$504.17M
P/E ratio
–
Price to sales
104.87
Price to book
97.31
Dividend yield
–
Free cash flow yield
-0.31%

Fundamentals

Revenue
$4.81M
Net income
-$22.65K
EPS, diluted
$0.00
Free cash flow
-$1.56M

Trading

Previous close
$29.35
Open
$29.35
Day's range
$29.35 – $29.35
Volume
0
52-week range
$19.01 – $31.70
RSI (14 days)
0.0
Volatility (1 year)
27.8%

Total return vs. the S&P 500

Price change plus reinvested dividends, to the close on Nov 5, 2026. The S&P 500 is measured by the SPY fund.

PeriodMCTAS&P 500DifferenceMCTA per yearS&P 500 per year
1 month-0.0%-5.4%+5.4 pts
3 months-0.0%-4.5%+4.5 pts
Year to date-0.0%+8.3%−8.3 pts
1 year+29.9%+9.3%+20.5 pts

Four years at a glance

Fiscal years 2023 to 2026, USD

Revenue

$4.81M-22.7% YoY

Gross profit

$4.77M-23.1% YoY

Operating income

-$29.24K-102.1% YoY

Net income

-$22.65K-101.9% YoY

EPS, diluted

$0.00-100.0% YoY

Free cash flow

-$1.56M-1224.2% YoY
Reported period

Press releases

Releases Charming Medical filed with the SEC as exhibits to Form 8-K or 6-K

All press releases and earnings

About Charming Medical

Services-Misc Health & Allied Services, NEC

Charming Medical Limited is a holding company that provides traditional Chinese medicine (TCM) inspired wellness and beauty services and products. Through its operating subsidiaries, the company delivers female-focused healthcare, including womb-warming therapies, pelvic detox treatments, moxibustion, prenatal and postpartum care, and abdominal binding. It also develops and sells herbal supplements, intimate washes, and skincare items under the Beauty Lab brand, offers technical consultancy and training to third-party salons, and provides tailored wellness and hair therapies for men. The business serves individual women across various life stages, male clients, and beauty care institutions.

Company profile, executives and history

Charming Medical stock: common questions

What is Charming Medical's stock price?

MCTA closed at $29.35 on Nov 5, 2026, up 0.00% on the day. Over the past 52 weeks it traded between $19.01 and $31.70.

What is Charming Medical's market cap?

Charming Medical was worth $504.17M at the close on Nov 5, 2026: the share price times the diluted shares outstanding.

What is MCTA's P/E ratio?

Charming Medical lost money over fiscal 2026 (diluted EPS $0.00), so it has no meaningful P/E ratio.

How much revenue does Charming Medical make?

Charming Medical reported revenue of $4.81M for fiscal 2026, down 22.7% from a year earlier.

Does Charming Medical pay a dividend?

No. Charming Medical has not paid a cash dividend over the last twelve months.

How has MCTA stock performed over the past year?

Including dividends, MCTA returned +29.9% over the past year, against +9.3% for the S&P 500.

How many MCTA shares are sold short?

1M shares were sold short at the latest FINRA report, 11.45% of the float, or 1000.0 days of average trading volume.

Who are Charming Medical's competitors?

Companies most similar to Charming Medical by business, industry and size include NIVF, ALPS, PFHO, EUDA, MRAI.

See a number that looks wrong?